Chromocell Therapeutics (CHRO) has had its best year since February 16, 2024 this year, returning 297%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Chromocell Therapeutics (CHRO) | 2024 | -89.32% |
Chromocell Therapeutics (CHRO) | 2025 | 297.01% |
